Citadel Advisors’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Buy |
+33,766
| New | +$268K | ﹤0.01% | 4723 |
|
|
2025
Q1 | – | Sell |
-1,507,192
| Closed | -$2.56M | – | 6985 |
|
|
2024
Q4 | $2.56M | Buy |
1,507,192
+64,724
| +4% | +$110K | ﹤0.01% | 2357 |
|
|
2024
Q3 | $4.9M | Sell |
1,442,468
-691
| -0% | -$2.35K | ﹤0.01% | 1786 |
|
|
2024
Q2 | $5.77M | Sell |
1,443,159
-722,652
| -33% | -$2.89M | ﹤0.01% | 1577 |
|
|
2024
Q1 | $7.39M | Buy |
2,165,811
+3,909
| +0.2% | +$13.3K | ﹤0.01% | 1481 |
|
|
2023
Q4 | $7.31M | Sell |
2,161,902
-4,211
| -0.2% | -$14.2K | ﹤0.01% | 1410 |
|
|
2023
Q3 | $11.7M | Sell |
2,166,113
-14,211
| -0.7% | -$76.6K | ﹤0.01% | 1070 |
|
|
2023
Q2 | $20.5M | Buy |
2,180,324
+18,528
| +0.9% | +$174K | ﹤0.01% | 805 |
|
|
2023
Q1 | $21.2M | Sell |
2,161,796
-2,120
| -0.1% | -$20.8K | ﹤0.01% | 825 |
|
|
2022
Q4 | $27M | Sell |
2,163,916
-2,551
| -0.1% | -$31.9K | 0.01% | 720 |
|
|
2022
Q3 | $19.7M | Buy |
2,166,467
+1,431
| +0.1% | +$13K | ﹤0.01% | 833 |
|
|
2022
Q2 | $5.47M | Buy |
2,165,036
+2,397
| +0.1% | +$6.05K | ﹤0.01% | 1780 |
|
|
2022
Q1 | $14.9M | Buy |
+2,162,639
| New | +$14.9M | ﹤0.01% | 1121 |
|